Imagerie par Résonance Magnétique (IRM) fonctionnelle de l'ischémie hépatique chez le Lapin. Contribution d'un agent de contraste particulaire (AMI-25)

Anatomia, Histologia, Embryologia

Volumn 25, Issue 1, 1996, Pages 23-29

  Canet, E ^a   Roger, T ^b   Chambon, C ^c   Delabre, C ^a   Baldy, C ^a   Revel, D ^a  

^a UNIVERSITÉ DE LYON   (France)

^b VETAGRO SUP   (France)

^c Laboratoire Guerbet   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ORYCTOLAGUS CUNICULUS;

CONTRAST MEDIUM; IRON; OXIDE; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL; ANIMAL DISEASE; ARTICLE; ISCHEMIA; LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; RABBIT; SUSPENSION; VASCULARIZATION;

ANIMALS; CONTRAST MEDIA; IRON; ISCHEMIA; LIVER; MAGNETIC RESONANCE IMAGING; OXIDES; RABBITS; SUSPENSIONS;

EID: 1842488248     PISSN: 03402096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0264.1996.tb00055.x     Document Type: Article

References (32)

1. Bacon, B. R., D. D. Stark and C. H. Park, 1987: Ferrite particles: a new magnetic resonance magnetic contrast agent. Lack of acute or chronic hepatotoxicity after intravenous administration. J. Lab. Clin. Med. 110, 164-171.
2. Barone, R., C. Pavaux, P. C. Blin and P. Cuq, 1966: Atlas d'Anatomie du Lapin. Paris: Masson et cie.
3. Berthezene, Y., D. Revel, C. Jacquet, A. Woerhle, C. Trepo and M. Amiel, 1990: Experimental study of hepatocellular carcinoma by MRI. Contribution of AMI 25 and AMI 25-Gd-DOTA combination in tumor detection. Diagn. Interv. Radiol. 2, 143-147.
4. Canet, E., D. Revel, R. Forrat, C. Baldy-Porcher, M. de Lorgeril, et al., 1993: SPIO's and positive enhancement for myocardial perfusion studies assessed by subsecond T1-weighted MRI. Magnetic Resonance Imaging 11, 1139-1145.
5. Chambon, C., O. Clement, A. le Blanche, E. Schouman-Claeys and G. Frija, 1993: Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence. Magn. Reson. Imaging. 11, 509-519.
6. Choi, B. I., M. C. Han and C. W. Kim, 1990: Small hepatocellular carcinoma versus small cavernous hemangioma: differentiation with MR imaging at 2.0 T. Radiology 176, 103-106.
7. Crooks, L. E., 1991: Some considerations for MR imaging of the liver. Radiology 180, 615-616.
8. Edelman, R. R., J. B. Siegel, A. Singer, K. Dupuis and H. E. Longmaid, 1989: Dynamic MR imaging of the liver with Gd-DTPA: initial clinical results. Am. J. Rad. 153, 1213-1219.
9. Egglin, T. K., E. Rummeny, D. D. Stark, J. Wittenberg, S. Saini and J. T. Ferrucci, 1990: Hepatic tumors: quantitative tissue characterization with MR imaging. Radiology 176, 107-110.
10. Ferrucci, J. T., 1990: Liver tumor imaging: current concepts. Am. J. Rad. 155, 473-484.
11. Ferrucci, J. T. and D. D. Stark, 1990: Iron oxide-enhanced MR imaging of the liver and spleen: review of the first five years. Am. J. Rad. 155, 943-950.
12. Gore, J. C. and S. Majumdar, 1990: Measurement of tissue blood flow using intravascular relaxation agents and Magnetic Resonance Imaging. Magn. Reson. Med. 14, 242-248.
13. Hahn, P. F., D. D. Stark, R. Weissleder, G. Elizondo, S. Saini and J. T. Ferrucci, 1990: Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumor. Radiology 174, 361-366.
14. Heiken, J. P., P. J. Weyman and J. K. T. Lee, 1989: Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography and MR imaging. Radiology 171, 47-51.
15. Josephson, L., J. Lewis, P. Jacobs, et al., 1988: The effects of iron oxides on proton relaxivity. Magn. Reson. Imaging. 6, 647-653.
16. Majumdar, S., S. S. Zoghbi and J. C. Gore, 1990: The influence of pulse sequence on the relaxation effects of superparamagnetic iron oxide contrast agents. Magn. Reson. Med. 10, 289-301.
17. Marchal, G., Y. Wi and B. van Damme, 1992: Role of contrast agent perfusion and diffusion in the NMR signal enhancement of liver lesions. J. Comput. Assist. Tomogr. 16, 690-698.
18. Marchal, G., P. van Hecke, P. Demacrel, E. Decrop and A. L. Baert, 1990: Iron oxide: high-field-MRI - Clinical results in: Ferrucci JT, Stark DD. Liver Imaging. Boston, Andover Medical Publishers.
19. Moonen, C. T. W., P. C. M. van Zijl, J. A. Frank, D. le Bihan and E. D. Becker, 1990: Functional Magnetic Resonance Imaging in medicine and physiology. Science. 250, 53-61.
20. Mukai, J. K., 1987: Imaging of surgically relevant hepatic vascular and segmental anatomy. Am. J. Rad. 149, 287-297.
21. Ranch, P. P., C. S. Owen, A. C. MacLaughlin, T. G. Frey and J. S. Leigh Jr., 1986: Ferromagnetic contrast agents: a new approach. Magn. Reson. Med. 3, 217-225.
22. Reimer, P., R. Weissleder and T. J. Brady, 1991: Experimental hepatocellular carcinoma: MR receptor imaging. Radiology 180, 641-645.
23. Reimer, P., R. Weissleder, V. Nickeleit and T. J. Brady, 1992: Animal models for magnetic resonance imaging research of the liver. Invest. Radiol. 5, 390-393.
24. Revel, D., C. Chambon and P. Havard, 1991: Iodinated polymer as blood-pool contrast agent. Computed tomography evaluation in rabbits. Invest. Radiol. 26, S57-S59.
25. Rosen, B. R., J. W. Belliveau, J. M. Vevea and T. J. Brady, 1990: Perfusion imaging with NMR contrast agents. Magn. Reson. Med. 14, 249-265.
26. Schuhmann-Giampieri, G., 1993: Liver contrast media for Magnetic Resonance Imaging. Interrelations between pharmacocinetics and imaging. Invest. Radiol. 28, 753-761.
27. Small, W. C., R. C. Nelson and M. E. Bernardino, 1993. Dual contrast enhancement of both T1 and T2-weighted sequences using ultrasmall superparamagnetic iron oxide. Magn. Reson. Imaging. 11, 645-654.
28. Stark, D. D., 1991: Physiological principles for the design of hepatic contrast agents. Magn. Reson. Med. 22, 324-328.
29. Tourniaire, J., 1993: Application de l'effet T1 de l'AMI-25 au diagnostic des hémangiomes hépatiques. Thèse doct. méd. Lyon, France.
30. Turner, R. and P. Keller, 1991: Angiography and perfusion measurements by NMR. Progress in NMR spectroscopy 23, 93-133.
31. Villin, B., 1965: Topographie vasculaire et biliaire du foie de quelques rongeurs domestiques. Thèse doct. vét. Alfort, France.
32. Weißleder, R., A. Bogdanov and M. Papisov, 1992: Drug targeting in magnetic resonance imaging. Magn. Reson. Quart. 8, 55-63.